Archives: Speakers

10+ years in Fintech, leading commercial teams within Payments & Banking at Wirecard and Solaris, currently working as VP Partnership at topi, taking care of our vendor and reseller programs

Steve joined PEAC Solutions in 2021 as part of the acquisition of the Barclays Asset Finance business. Steve has over 30 years of experience in the leasing and financial services industry, working across both general equipment (asset) finance and full-service vehicle leasing. In his capacity as CEO of PEAC Solutions UK, he is responsible for all aspects of local market business operations including Sales, Credit and Asset Risk Management, Finance and Accounting, Compliance, Operations, IT and Human Resources.

Prior to joining PEAC Solutions, Steve worked at Barclays Bank for 18 years, where he held positions of increasing scope and responsibility, culminating with his appointment as Head of Barclays Asset Finance in 2019. In addition to his day-to-day responsibilities, Steve has also spent over eight years on the main board of the Finance and Leasing Association, the UK Leasing Trade Body, including two years as Chairperson for the Asset Finance Division. Previously, he also spent three years on the board of Motability Operations Group plc., a company that provides sustainable mobility solutions to more than 700,000 people with disabilities in the UK.

Abigail Beaney is the editor of Clinical Trials Arena. Abigail has expertise in clinical trial regulation, trial design, outsourcing, and cell and gene therapies. Abigail also has covered news and has a wealth of knowledge across several therapy areas including neurodegenerative, infectious and metabolic diseases. Abigail holds a first-class BA (Hons) degree in Journalism from the University of Central Lancashire in the United Kingdom. She has also obtained the National Qualification in Journalism through the UK’s media industry body, the National Council for the Training of Journalists

Matteo brings a multidisciplinary perspective to clinical innovation, with experience across banking, academia, government, and the private sector. He has worked internationally in Canada, Italy, the U.S., Spain, and Romania, gaining firsthand insight into diverse healthcare challenges. His career spans start-ups, scale-ups, and multinational corporations, sharpening skills in leadership, strategy, and solution-building. At Biorce, an AI-driven organization, he focuses on transforming drug development and clinical trials, making life-changing treatments for rare diseases more accessible through advanced technology and human insight.

I am a Health and Technology (wearables, sensors, IoTs, hybrids) Management specialist with Business Development focus. Currently, I work with 2 Digital Health start-ups in Vienna, Austria and Dhaka, Bangladesh, as well as at the Ministry of Immigration and Diversity of Austria. I collaborate with different research initiatives on Diabetes & CVD Management, Mental Health Management of Researchers (COST Action EU) and remote monitoring. I support establishment & up-scaling health start-ups’ technological, procedural and economic innovations to effect optimization of the Chain of Care. For me, Care is personalized, holistic, multidisciplinary involving individuals and organizations in an integrated, dynamic, and interactive system. I have a multidisciplinary background including Dentistry (Bachelor of Dental Surgery, Dhaka Dental College, Bangladesh), Public Health (Master with distinction, James P. Grant School of Public Health, Bangladesh), Health Care Management and Technology Management (Master, University of Twente, The Netherlands). Professionally, I gained competencies in Management (Health, technology, business, R&D, Policy), Business (Strategy, project management, main streaming), Networking and Advocacy. Result-oriented, problem-based, participatory, innovative, and holistic approach to analyzation and finding scalable, sustainable solutions are my strong points.

João Gonçalo Nascimento is a Performance Analyst at Pfizer, specialising in clinical trial feasibility and generative AI integration. He holds a master’s in Biomedical Engineering and has six years’ experience in healthcare, with four in Pharma. Previously, João managed international projects at BIQ Health Solutions and supported site intelligence at Pfizer before moving into his current strategic role, where he develops business-level requirements for process optimisation initiatives using genAI.

Jakob Teschke, Head of Business Model Innovation, Siemens Financial Services GmbH

Jakob Teschke serves as Head of Business Model Innovation at Siemens Financial Services (SFS), where he leads the development of innovative, data-driven, and sustainable business models in collaboration with Siemens’ industrial businesses, customers, and partners. He is also responsible for the platform strategy and offerings at SFS, driving AI-powered digital transformation initiatives across core processes and shaping the company’s AI strategy.

Prior to joining Siemens, Jakob held different consulting roles at Accenture from 2017 to 2020, specializing in digital transformation within corporate banking. From 2009 to 2016, he worked at Commerzbank AG, primarily in corporate banking and later in the bank’s in-house consulting division.

Mike Brooks is a seasoned cybersecurity sales leader with over a decade of experience helping enterprise organisations modernise and secure their digital environments. As Senior Enterprise Account Executive at Abnormal AI, he partners with leading UK enterprises to transform their email security and reduce risk through AI-driven behavioural defence.

Before joining Abnormal, Mike held senior roles at Palo Alto Networks, Fortinet, and F5 Networks, where he built and led strategic relationships with large financial services, cloud, and managed service providers. His expertise spans enterprise sales strategy, business transformation, and cybersecurity architecture, with a consistent focus on aligning technology to customer outcomes.

John Flatley is a Solutions Engineer at Abnormal AI with deep, hands-on expertise in email security built over more than 15 years in the industry. Having joined Abnormal, he now advises enterprise customers across EMEA on advanced, AI-driven approaches to securing the inbox.

Before Abnormal, John spent six years at Barracuda in senior pre-sales roles, including heading up their email strategy across EMEA as a Consulting Solutions Architect, where he worked directly with security teams across the region to solve complex email threats. His earlier career at CMS Distribution saw him supporting and architecting the internal systems as an IT Manager, giving him an end-to-end understanding of the email threat landscape and the tools that truly work to stop it.

Josh’s 16 year tenure with BlueFort and has honed his expertise as a technology leader, delivering best of breed value driven solutions in both public and private sector. As CTO, Josh orchestrates the strategic direction of BlueFort’s technological endeavours, leveraging his extensive experience in the ever changing and challenging cyber security landscape. By staying ahead of the curve in the latest security trends and methodologies, Josh ensures that Bluefort delivers the cyber safeguarding clients need, while maintaining trust in protecting against adversaries. His diverse skill set encompasses not only technical proficiency (incl. design, architecture, and implementation) but also a deep understanding of how cyber security plays a major role in business objectives, enabling him to align technology initiatives with organisational goals.